Tumor Lysis Syndrome
📧 Sign up to get email alerts when something new happens for Tumor Lysis Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-01-09Clinical Trial Update: Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome
This clinical trial evaluates the timing of initiating renal replacement therapy in patients with tumor lysis syndrome–associated acute kidn…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome [Phase 4]
Phase 4 clinical trial update examining pegloticase for lowering uric acid in patients with tumor lysis syndrome; the study is active but no…
-
FDA label_change · 2025-10-16FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA granted a supplemental approval for ALLOPURINOL submitted by Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. to update the prod…
-
FDA approval · 2025-06-13FDA Approved: ALLOPURINOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Allopurinol from Zydus Lifesciences Limited.
-
FDA approval · 2025-04-14FDA Approved: ALLOPURINOL — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Allopurinol from Aurobindo Pharma Limited, authorizing a generic version of allopurinol.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-02-11FDA Approved: ALLOPURINOL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Allopurinol from Accord Healthcare Inc., indicating an additional approval for the generic produ…
-
FDA approval · 2024-08-30FDA Approved: ALLOPURINOL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Allopurinol from Camber Pharmaceuticals, Inc. under the ANDA program. This action constitutes a …
-
FDA approval · 2024-04-03FDA Approved: ALLOPURINOL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Allopurinol from Actavis Pharma, Inc., authorizing changes to the product’s labeling.
-
FDA label_change · 2024-03-08FDA Approved: ALLOPURINOL — Supplemental Application (Harman Finochem Limited)
FDA approved a supplemental application for Allopurinol, approving changes to the labeling for Harman Finochem Limited's generic Allopurinol…
-
FDA approval · 2024-02-16FDA Approved: ALLOPURINOL — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for Allopurinol submitted by Par Health USA, LLC.
-
FDA approval · 2024-02-05FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for allopurinol from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals) under ANDA204467. The app…
-
FDA approval · 2024-02-05FDA Approved: ALLOPURINOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for ALLOPURINOL (Allopurinol) submitted by Zydus Lifesciences Limited, authorizing changes to the ap…
-
FDA approval · 2024-01-29FDA Approved: ALLOPURINOL — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Allopurinol from Sun Pharmaceutical Industries, Inc., indicating an approved update to the drug'…
-
FDA label_change · 2024-01-29FDA Approved: ALLOPURINOL — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Allopurinol submitted by Unichem Pharmaceuticals (USA), Inc., resulting in changes to the produc…
-
FDA approval · 2023-03-15FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Allopurinol from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under ANDA204…
-
FDA approval · 2022-08-08FDA Approved: ALLOPURINOL — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application from Gland Pharma Limited for Allopurinol, enabling the marketing of a generic Allopurinol product u…
-
FDA approval · 2022-08-04FDA Approved: ALLOPURINOL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for allopurinol submitted by Rising Pharma Holdings, Inc. This action authorizes a post-approval…
-
FDA approval · 2022-03-07FDA Approved: ALLOPURINOL — Original Application (Harman Finochem Limited)
FDA approves the original application for Allopurinol from Harman Finochem Limited.
-
FDA approval · 2022-02-17FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC.
-
FDA approval · 2022-01-26FDA Approved: ALLOPURINOL — Original Application (Gland Pharma Limited)
FDA approved the original application for allopurinol from Gland Pharma Limited, enabling a generic version in the United States.
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults [Phase 1, Phase 2]
Clinical trial evaluating febuxostat for prevention of tumor lysis syndrome in pediatric and adult patients with hematological malignancies;…
-
FDA approval · 2020-08-28FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC. The action relates to updates in the…
-
FDA approval · 2019-12-12FDA Approved: ELITEK — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for ELITEK (rasburicase) submitted by Sanofi-Aventis U.S. LLC.
-
FDA label_change · 2019-04-23FDA Approved: ALLOPURINOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for allopurinol submitted by Zydus Lifesciences Limited, indicating changes to the product labeling.
-
FDA approval · 2019-03-19FDA Approved: ALLOPURINOL — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for allopurinol (generic) submitted by Chartwell RX, LLC.